Mecasia, Rissa Mae .
HRN: 27-81-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2025
MUPIROCIN 2%, 15G (TUBE)
09/29/2025
10/05/2025
TOPICAL
1ml
OD
SP LTCS
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes